Histologic and Liquid Chromatography Mass Spectrometry (LCMS) Evaluation of the Sebaceous Gland Changes Induced by Clascoterone Cream 1%
Latest Information Update: 21 Feb 2025
Price :
$35 *
At a glance
- Drugs Clascoterone (Primary)
- Indications Acne; Acne vulgaris
- Focus Therapeutic Use
- Sponsors Sun Pharmaceutical Industries
- 17 Feb 2025 Planned End Date changed from 1 Dec 2024 to 1 Sep 2025.
- 17 Feb 2025 Planned primary completion date changed from 1 Dec 2024 to 1 Sep 2025.
- 25 Oct 2024 According to a Sun Pharma media release, company announced today , interim analysis 12 week data from this trial will be presented in a poster at the 44th Annual Fall Clinical Dermatology Conference, being held Oct 24-27, 2024, in Las Vegas, Nevada.